Wuyts A, Schutyser E, Menten P, Struyf S, D'Haese A, Bult H, Opdenakker G, Proost P, Van Damme J
Laboratory of Molecular Immunology, Rega Institute for Medical Research, University of Leuven, B-3000 Leuven, Belgium.
Biochemistry. 2000 Nov 28;39(47):14549-57. doi: 10.1021/bi0011227.
The role of interleukin-8 (IL-8) and related CXC chemokines has been demonstrated in many human diseases. However, more profound studies, e.g., by blocking the effect of these inflammatory mediators, request animal models and hence the identification of all human counterparts for commonly used laboratory animals. In this study, we describe the identification of a novel neutrophil chemotactic protein (NCP) of the rabbit. Intact and NH(2)-terminally truncated NCP forms and IL-8 were isolated from LPS-stimulated rabbit alveolar macrophages and purified to homogeneity by a four-step purification procedure. Determination of the complete primary structure of NCP by mass spectrometry and NH(2)-terminal sequencing of natural protein revealed high structural homology with human epithelial cell-derived neutrophil attractant-78 (ENA-78) and granulocyte chemotactic protein-2 (GCP-2), two related ELR(+)CXC chemokines. Intact NCP(1-76) was found to be 10-fold less potent than truncated NCP(7, 8-76) at inducing neutrophil chemotaxis. NCP(7,8-76) was equally potent as intact rabbit IL-8 at chemoattracting human neutrophils and at inducing calcium fluxes in rabbit neutrophils, 1 ng/mL being the minimal effective concentration. However, like IL-8, NCP failed to induce monocyte or eosinophil migration at 300-fold higher concentrations. IL-8 desensitized the calcium increase induced by NCP and vice versa. Finally, intradermal injection of NCP induced a dose-dependent and significant infiltration of neutrophils in mice skin. It can be concluded that NCP is a novel rabbit CXC chemokine that is, like IL-8, implicated in animal models used to study various human disorders in which neutrophils play an important role.
白细胞介素-8(IL-8)及相关CXC趋化因子在多种人类疾病中的作用已得到证实。然而,更深入的研究,例如通过阻断这些炎症介质的作用,则需要动物模型,因此需要鉴定常用实验动物的所有人类对应物。在本研究中,我们描述了一种新型兔中性粒细胞趋化蛋白(NCP)的鉴定。从脂多糖刺激的兔肺泡巨噬细胞中分离出完整的和氨基末端截短的NCP形式以及IL-8,并通过四步纯化程序将其纯化至同质。通过质谱法测定NCP的完整一级结构以及天然蛋白的氨基末端测序显示,其与人类上皮细胞衍生的中性粒细胞吸引剂-78(ENA-78)和粒细胞趋化蛋白-2(GCP-2)这两种相关的ELR(+)CXC趋化因子具有高度的结构同源性。发现在诱导中性粒细胞趋化方面,完整的NCP(1-76)的效力比截短的NCP(7, 8-76)低10倍。在趋化人类中性粒细胞以及诱导兔中性粒细胞钙流方面,NCP(7,8-76)与完整的兔IL-8效力相当,最低有效浓度为1 ng/mL。然而,与IL-8一样,NCP在浓度高300倍时未能诱导单核细胞或嗜酸性粒细胞迁移。IL-8使NCP诱导的钙增加脱敏,反之亦然。最后,皮内注射NCP可诱导小鼠皮肤中中性粒细胞呈剂量依赖性且显著浸润。可以得出结论,NCP是一种新型兔CXC趋化因子,与IL-8一样,参与用于研究各种人类疾病的动物模型,在这些疾病中中性粒细胞起重要作用。